Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival

Oncogene

Volumn 23, Issue 21, 2004, Pages 3770-3780

  Cheng, Ningli ^a   Janumyan, Yelena M ^b   Didion, Lisa ^a   Van Hofwegen, Chris ^a   Yang, Elizabeth ^b   Knudson, C Michael ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Apoptosis; Bax; Bcl 2; p27; Proliferation; Quiescent; T cells

Indexed keywords

PROTEIN BCL 2; ACTIN BINDING PROTEIN; BAX PROTEIN, MOUSE; MUSCLE PROTEIN; ONCOPROTEIN; PROTEIN BAX; PROTEIN KINASE LCK; PYRONINE; TAGLN PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL ISOLATION; CELL LINE; CELL MUTANT; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE; AGE; ANIMAL; APOPTOSIS; CELL CYCLE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALIA;

AGE FACTORS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL SURVIVAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRONINE; T-LYMPHOCYTES;

EID: 2342566366     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207478     Document Type: Article

References (43)

1. Bairey O, Zimra Y, Shaklai M, Okon E and Rabizadeh E. (1999). Clin. Cancer Res., 5, 2860-2866.
2. Buglioni S, D'Agnano I, Cosimelli M, Vasselli S, D'Angelo C, Tedesco M, Zupi G and Mottolese M. (1999). Int. J. Cancer, 84, 545-552.
3. Bureau F, Vanderplasschen A, Jaspar F, Minner F, Pastoret PP, Merville MP, Bours V and Lekeux P. (2002). Blood, 99, 3683-3691.
4. Chao DT and Korsmeyer SJ. (1998). Annu. Rev. Immunol., 16, 395-419.
5. Darzynkiewicz Z, Sharpless T, Staiano-Coico L and Melamed MR. (1980). Proc. Natl. Acad. Sci. USA, 77, 6696-6699.
6. de la Coste A, Mignon A, Fabre M, Gilbert E, Porteu A, Van Dyke T, Kahn A and Perret C. (1999). Cancer Res., 59, 5017-5022.
7. Garvin AM, Abraham KM, Forbush KA, Farr AG, Davison BL and Perlmutter RM. (1990). Int. Immunol., 2, 173-180.
8. Greider C, Chattopadhyay A, Parkhurst C and Yang E. (2002). Oncogene, 21, 7765-7775.
9. Gross A, McDonnell JM and Korsmeyer SJ. (1999). Genes Dev., 13, 1899-1911.
10. Harris MH and Thompson CB. (2000). Cell Death Differ., 7, 1182-1191.
11. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ. (1990). Nature, 348, 334-336.
12. Hogarth LA and Hall AG. (1999). Blood, 93, 2671-2678.
13. Horton RM, Ho SN, Pullen JK, Hunt HD, Cai Z and Pease LR. (1993). Methods Enzymol., 217, 270-279.
14. Huang DC, O'Reilly LA, Strasser A and Cory S. (1997). EMBO J., 16, 4628-4638.
15. Janumyan YM, Sansam CG, Chattopadhyay A, Cheng NL, Soucie EL, Penn LZ, Andrews D, Knudson CM and Yang E. (2003). EMBO J., 22, 5459-5470.
16. Kaklamanis L, Savage A, Whitehouse R, Doussis-Anagnostopoulou I, Biddolph S, Tsiotos P, Mortensen N, Gatter KC and Harris AL. (1998). Br. J. Cancer, 77, 1864-1869.
17. Kennedy NJ, Kataoka T, Tschopp J and Budd RC. (1999). J. Exp. Med., 190, 1891-1895.
18. Knudson CM, Johnson GM, Lin Y and Korsmeyer SJ. (2001). Cancer Res., 61, 659-665.
19. Knudson CM and Korsmeyer SJ. (1997). Nat. Genet., 16, 358-363.
20. Linette GP, Hess JL, Sentman CL and Korsmeyer SJ. (1995). Blood, 86, 1255-1260.
21. Linette GP, Li Y, Roth KA and Korsmeyer SJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 9545-9552.
22. Luke JJ, Van de Wetering CI and Knudson CM. (2003). Cell Death Differ., 10, 740-748.
23. MacCarthy-Morrogh L, Mouzakiti A, Townsend P, Brimmell M and Packham G. (1999). Biochem. Soc. Trans., 27, 785-789.
24. Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, Srivastava S and Grizzle WE. (1997). Int. J. Cancer, 74, 346-358.
25. Marvel J, Perkins GR, Lopez Rivas A and Collins MK. (1994). Oncogene, 9, 1117-1122.
26. Meterissian SH, Kontogiannea M, Al-Sowaidi M, Linjawi A, Halwani F, Jamison B and Edwardes M. (2001). Ann. Surg. Oncol., 8, 533-537.
27. Murphy KL, Kittrell FS, Gay JP, Jager R, Medina D and Rosen JM. (1999). Oncogene, 18, 6597-6604.
28. Newton K, Harris AW, Bath ML, Smith KGC and Strasser A. (1998). EMBO J., 17, 706-718.
29. Ofner D, Riehemann K, Maier H, Riedmann B, Nehoda H, Totsch M, Bocker W, Jasani B and Schmid KW. (1995). Br. J. Cancer, 72, 981-985.
30. Oltvai ZN, Milliman CL and Korsmeyer SJ. (1993). Cell, 74, 609-619.
31. O'Reilly LA, Harris AW and Strasser A. (1997a). Int. Immunol., 9, 1291-1301.
32. O'Reilly LA, Harris AW, Tarlinton DM, Corcoran LM and Strasser A. (1997b). J. Immunol., 159, 2301-2311.
33. O'Reilly LA, Huang DC and Strasser A. (1996). EMBO J., 15, 6979-6990.
34. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 3714-3717.
35. Rathmell JC, Vander Heiden MG, Harris MH, Frauwirth KA and Thompson CB. (2000). Mol. Cell, 6, 683-692.
36. Rossiter H, Beissert S, Mayer C, Schon MP, Wienrich BG, Tschachler E and Kupper TS. (2001). Cancer Res., 61, 3619-3626.
37. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ. (1991). Cell, 67, 879-888.
38. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Difronzo G, Rilke F and Veronesi U. (1994). J. Natl. Cancer Inst., 86, 499-504.
39. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S and Harris AW. (1991). Proc. Natl. Acad. Sci. USA, 88, 8661-8665.
40. Tsujimoto Y, Gorham J, Cossman J, Jaffe E and Croce CM. (1985). Science, 229, 1390-1393.
41. Uhlmann EJ, Dsaeipper C, Subramanian T, Wagner AJ, Hay N and Chinnadurai G. (1996). Cancer Res., 56, 2506-2509.
42. Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME, Koff A and Adams JM. (2000). Mol. Cell. Biol., 20, 4745-4753.
43. Vaux DL, Cory S and Adams JM. (1988). Nature, 335, 440-442.